Spindle cell Oncocytomas and granular cell tumors of the pituitary are variants of Pituicytoma

American Journal of Surgical Pathology

Volumn 37, Issue 11, 2013, Pages 1694-1699

  Mete, Ozgur ^a   Lopes, Maria Beatriz ^b   Asa, Sylvia L ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

BRAF; folliculostellate cells; granular cell tumor; IDH1; olig2; pituicytes; pituicytoma; spindle cell oncocytoma; TTF 1; ultrastructure

Indexed keywords

ONCOPROTEIN; TUMOR MARKER;

ARTICLE; BIOPSY; CHEMISTRY; CLASSIFICATION; ELECTRON MICROSCOPY; GENETICS; GRANULAR CELL TUMOR; HUMAN; HYPOPHYSIS TUMOR; IMMUNOHISTOCHEMISTRY; MUTATION; NOMENCLATURE; NUCLEOTIDE SEQUENCE; ONCOCYTOMA; PATHOLOGY; PREDICTIVE VALUE; ULTRASTRUCTURE;

ADENOMA, OXYPHILIC; BIOPSY; DNA MUTATIONAL ANALYSIS; GRANULAR CELL TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON; MUTATION; ONCOGENE PROTEINS, FUSION; PITUITARY NEOPLASMS; PREDICTIVE VALUE OF TESTS; TERMINOLOGY AS TOPIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84886428435     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31829723e7     Document Type: Article

References (31)

1. Brat DJ, Scheithauer BW, Fuller GN, et al. Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain Pathol. 2007;17:319-324.
2. Brat DJ, Scheithauer BW, Staugaitis SM, et al. Pituicytoma: a distinctive low-grade glioma of the neurohypophysis. Am J Surg Pathol. 2000;24:362-368.
3. Louis DN, Ohgaki H, Wiestler OD, et al. WHO classification of Tumors of the Central Nervous System. Lyon: IARC; 2007.
4. Asa SL. Tumors of the pituitary gland. Fascicle 15, 4th series. In: Silverberg SG, Gardner WA, Sobin LH, eds. The Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology; 2011.
5. Policarpio-Nicolas ML, Le BH, Mandell JW, et al. Granular cell tumor of the neurohypophysis: report of a case with intraoperative cytologic diagnosis. Diagn Cytopathol. 2008;36:58-63.
6. Roncaroli F, Scheithauer BW, Cenacchi G, et al. Spindle cell oncocytoma of the adenohypophysis: a tumor of folliculostellate cells? Am J Surg Pathol. 2002;26:1048-1055.
7. Inoue K, Couch EF, Takano K, et al. The structure and function of folliculo-stellate cells in the anterior pituitary gland. Arch Histol Cytol. 1999;62:205-218.
8. Alexandrescu S, Brown RE, Tandon N, et al. Neuron precursor features of spindle cell oncocytoma of adenohypophysis. Ann Clin Lab Sci. 2012;42:123-129.
9. Lee EB, Tihan T, Scheithauer BW, et al. Thyroid transcription factor 1 expression in sellar tumors: a histogenetic marker? J Neuropathol Exp Neurol. 2009;68:482-488.
10. Takei Y, Seyama S, Pearl GS, et al. Ultrastructural study of the human neurohypophysis. II. Cellular elements of neural parenchyma, the pituicytes. Cell Tissue Res. 1980;205:273-287.
11. Mete O, Asa SL. Neuronal cell tumors, pituitary gland. In: Nose V, ed. Diagnostic Pathology: Endocrine. Salt Lake City, UT: Amirsys; 2012:60-65.
12. Cenacchi G, Giovenali P, Castrioto C, et al. Pituicytoma: ultrastructural evidence of a possible origin from folliculo-stellate cells of the adenohypophysis. Ultrastruct Pathol. 2001;25:309-312.
13. Lazzaro D, Price M, de Felice M, et al. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development. 1991;113:1093-1104.
14. Kimura S, Hara Y, Pineau T, et al. The T/ebp null mouse: thyroidspecific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev. 1996;10:60-69.
15. Ordo n ez NG. Value of thyroid transcription factor-1 immunostaining in tumor diagnosis: a review and update. Appl Immunohistochem Mol Morphol. 2012;20:429-444.
16. Takuma N, Sheng HZ, Furuta Y, et al. Formation of Rathkes pouch requires dual induction from the diencephalon. Development. 1998;125:4835-4840.
17. Vajtai I, Beck J, Kappeler A, et al. Spindle cell oncocytoma of the pituitary gland with follicle-like component: organotypic differentiation to support its origin from folliculo-stellate cells. Acta Neuropathol. 2011;122:253-258.
18. Zamecnik J, Chanova M, Kodet R. Expression of thyroid transcription factor 1 in primary brain tumours. J Clin Pathol. 2004;57:1111-1113.
19. Coates PJ, Doniach I. Development of folliculo-stellate cells in the human pituitary. Acta Endocrinol (Copenh). 1988;119: 16-20.
20. Ligon KL, Fancy SP, Franklin RJ, et al. Olig gene function in CNS development and disease. Glia. 2006;54:1-10.
21. Geha S, Pallud J, Junier MP, et al. NG2+/Olig2+ cells are the major cycle-related cell population of the adult human normal brain. Brain Pathol. 2010;20:399-411.
22. Otero JJ, Rowitch D, Vandenberg S. OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms. J Neurooncol. 2011;104:423-438.
23. Kinjo S, Hirato J, Nakazato Y. Low grade diffuse gliomas: shared cellular composition and morphometric differences. Neuropathology. 2008;28:455-465.
24. Entrez Gene: OLIG2 oligodendrocyte lineage transcription factor 2. Available at:http://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd= ShowDetailView&TermToSearch=10215. Accessed February 25, 2013.
25. Phillips JJ, Misra A, Feuerstein BG, et al. Pituicytoma: characterization of a unique neoplasm by histology, immunohistochemistry, ultrastructure, and array-based comparative genomic hybridization. Arch Pathol Lab Med. 2010;134:1063-1069.
26. von Deimling A, Korshunov A, Hartmann C. The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations. Brain Pathol. 2011;21:74-87.
27. Korshunov A, Meyer J, Capper D, et al. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma. Acta Neuropathol. 2009;118:401-405.
28. Dubbink HJ, Taal W, van Marion R, et al. IDH1 mutations in lowgrade astrocytomas predict survival but not response to temozolomide. Neurology. 2009;73:1792-1795.
29. Sanson M, Marie Y, Paris S, et al. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol. 2009;27:4150-4154.
30. Jeuken JW, Wesseling P.MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential. J Pathol. 2010;222:324-328. Erratum in: J Pathol. 2011;223:446.
31. Forshew T, Tatevossian RG, Lawson AR, et al. Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol. 2009;218:172-181